5th Annual
Clinical Trial
Innovation Summit
Innovation Summit
26 JUNE 2025 | BASEL | ROCHE BUILDING 1
PRESENTED BY
The Clinical Trial Innovation Summit Returns to Roche Headquarters in Basel on 26 June 2025!
PanAgora Pharma and Roche are collaborating once again to bring the 5th Annual Clinical Trial Innovation Summit back to Basel this 26 June! This year's conference agenda will explore how life sciences organizations are delivering more patient-centric clinical trials and how digital health technologies (DHTs) are being implemented to improve efficacy measurement, patient recruitment, safety, and drug delivery.
Core themes and topics for the 2025 agenda include:
• Industry Trends and Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHT, Decentralized trials, Evolving Role of CRO’s, Global Perspective
• Patient Perspective: Keys to Engagement, Involvement, and Applying Learnings at Scale
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials
• Ideas into Action: Keys to Delivering Inclusive Human-Centered Clinical Trials
Join 30+ speakers and 250+ senior-level clinical research, operations, and trial design leaders on 26 June at Roche headquarters in Basel!
Location
Date & Time
26 June 2025
09:00-17:30 Local Time (GMT+2)
Apéro to Follow
09:00-17:30 Local Time (GMT+2)
Apéro to Follow
HOST SPONSOR
AGENDA THEMES
1. Industry Trends and Latest Innovations: AI, DHTs, Decentralised Trials
2. Accelerating Patient-Centric Trials: Innovations & Technologies
3. Enhancing Diversity in Clinical Trials: Stakeholder Perspectives
4. Ideas into Action: Delivering Human-Centered Clinical Trials
Speaking Faculty & Advisors
Sam Hariry
NOVARTIS
Léa Proulx
ROCHE
Ernst Bos
ROCHE
Paul Cooper
ROCHE
Bola Grace
GSK
Scott Askin
NOVARTIS
Nadir Ammour
SANOFI
Isabela Niculae
UCB
Suki Balendra
IMPERIAL COLLEGE HEALTHCARE NHS TRUST
Meri Kay Scott
ELI LILLY AND COMPANY
Dan Karlin
MINDMED
Lauren Sunshine
BMS
Angela Bilkhu
ROCHE
Joachim Lövin
NOVO NORDISK
Matteo Lai
EMPATICA
Thierry Lave
ROCHE
Sebastian Heinzmann
ROCHE
Marco Rafael
ROCHE
Steve Bourke
PERSONALPULSE
Amri Johnson
INCLUSION WINS
Alison Holland
MEDABLE
Aude Clement
ROCHE
Bruno Jolain
ROCHE
Thierry Lave
ROCHE
Lorcan Walsh
NOVARTIS
Judit Magos
IDORSIA
Richard Bobek
MSD
Stephan Cichos
BAYER
CoNFERENCE SCHEDULE
26 June 2025
09:00
Opening Remarks from the Conference Chairs
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
CONTENT BLOCK 1
INDUSTRY TRENDS AND INNOVATIONS
09:05
FIRESIDE EXPERT KICK-OFF
Industry Trends: Innovations in Clinical Trial Design and Execution
“What does it take to make the EU clinical trial landscape more competitive?”
Industry Trends: Innovations in Clinical Trial Design and Execution
“What does it take to make the EU clinical trial landscape more competitive?”
• EU Policy
• Innovations in Design (AI/ML, Knowledge Management)
• Innovations in Execution (DHTs, Decentralized Trials, and Site Experience)
Isabela Niculae, Head, Clinical Innovation and Digital Solutions, Global Clinical Operations, UCB
Joachim Lövin, Decentralised Clinical Trial (DCT) Specialist, Novo Nordisk
Lorcan Walsh, Head, Digital Endpoint Capability Centre, Development, Novartis
Moderated by: Marco Rafael, Regulatory Science Policy Leader, Roche
09:30
CASE STUDY
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
• Roche's Approach and Leadership in Data Re-use - ROI and Responsibility to Patients
• Development of Datamarts to Generate Insights for Study and CDP Design
Marta Carrasco, Biomedical Data Insights Development Leader, Roche
09:50
CASE STUDY
Patient Recruitment Enabled through EHRs
Patient Recruitment Enabled through EHRs
Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi
10:10
AI-Driven Clinical Trials: Accelerating Patient-Centric Breakthroughs in Research and Efficiency
Alison Holland, Chief Customer Officer, Medable
10:30
Networking Break
CONTENT BLOCK 2
Accelerating Patient-Centric Trials
Accelerating Patient-Centric Trials
11:00
CASE STUDY
Navigating Operational Challenges of Multimodal DHT Trials
Navigating Operational Challenges of Multimodal DHT Trials
Speaker TBA
11:20
CASE STUDY
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
This session will explore how Novartis’s Clin Ops Innovation team is transforming clinical operations. Discover how their comprehensive operating model scales innovation through a structured framework, ensuring alignment with operational needs and challenges. Learn how they measure success with clear criteria, match specific innovations to operational requirements, and consistently assess the innovation landscape to identify new opportunities. This session will provide valuable insights into Novartis’s systematic approach to driving sustainable, value-driven innovation in clinical trials.
Scott Askin, Portfolio Innovation Director, Global Clinical Operations, Novartis
11:40
Bringing Clinical Trials Direct-to-Patient
Rachel Newsome, Product Manager, Cambridge Cognition
12:00
PANEL
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Lauren Sunshine, Director, Product Management, Digital Health, Bristol Myers Squibb
Bola Grace, Senior Director, Digital Health, Digital Biomarkers, GSK
Sam Hariry, Global Head, Clinical Innovation, Novartis Institutes for BioMedical Research (NIBR)
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
Moderated by: Judit Magos, Clinical Operations Manager, Idorsia
12:30
NETWORKING LUNCH
CONTENT BLOCK 3
Enhancing Diversity in Clinical Trials
Enhancing Diversity in Clinical Trials
13:30
PANEL
Patient Perspectives & Cultural Considerations in Clinical Trials
Patient Perspectives & Cultural Considerations in Clinical Trials
This panel will bring together a group of patients to explore how their perspectives on cultural considerations in clinical trials.
Moderated by: Steve Bourke, Founder, PersonalPulse
13:50
CASE STUDY
End to End Inclusive Research
End to End Inclusive Research
What can early development bring to late stage development?
Thierry Lave, R&D Academy and Faculty Lead, Roche
14:10
CASE STUDY
IHI READI
IHI READI
This session will explore the collaboration behind the IHI-funded project - IHI READI - aimed at fostering a more cohesive and integrated clinical studies ecosystem for underserved (US) and underrepresented (UR) communities.
Lea Proulx, Patient Voice Partner, Roche
14:30
CASE STUDY
Frailty Diversity in Oncology Trials
Frailty Diversity in Oncology Trials
Sebastian Heinzmann, Global Medical Science Leader, Roche
14:50
NETWORKING BREAK
CONTENT BLOCK 4
IDEAS INTO ACTION
IDEAS INTO ACTION
15:15
CASE STUDY
Technology Fit for Purpose:
Understanding of Potential Issues to Decrease Patient Burden On Your Study
Technology Fit for Purpose:
Understanding of Potential Issues to Decrease Patient Burden On Your Study
Stephan Cichos, Strategic Project Leader, Clinical Data Strategy & Operations, Bayer
15:35
CASE STUDY
How MindMed is Deploying AI to do Analysis of Patient Interviews Around the Primary Endpoint of All Clinical Studies
How MindMed is Deploying AI to do Analysis of Patient Interviews Around the Primary Endpoint of All Clinical Studies
Dan Karlin, Chief Medical Officer, MindMed
15:55
CASE STUDY
MSD’s In-House Site Selection Application – Data-Driven Performance Ranking for Optimized Clinical Trials
MSD’s In-House Site Selection Application – Data-Driven Performance Ranking for Optimized Clinical Trials
Richard Bobek, Associate Director, Clinical Data Science, MSD
16:15
Patient Perspective: First Hand Experience with DCTs
Patient Speaker TBA
16:30
CLOSING PANEL
DHTs in Clinical Trials: Reality Check and Key Takeaways from Patient and Site Interactions
DHTs in Clinical Trials: Reality Check and Key Takeaways from Patient and Site Interactions
Meri Kay Scott, Associate Vice President, Digital Health R&D, Eli Lilly & Company
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
Matteo Lai, Chief Executive Officer, Empatica
16:55
Closing Reflection
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
17:00
APÉRO & NETWORKING RECEPTION!
Sponsors & Exhibitors
HOST SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
SUPPORTING SPONSOR
SUPPORTING SPONSOR
Interested in Sponsorship or
Exhibition Opportunities?
Exhibition Opportunities?
Conference Venue
Roche Tower (Building 1)
The Clinical Trials Innovation Summit (26 June) and the Digital Biomarkers Summit (25 June) will both be held in the Auditorium of Building 1 on the Roche campus in Basel.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Hotel Room Block
Hyperion Hotel Basel
(4 Star Hotel) Hyperion Hotel Basel in Basel, Switzerland
Location: Messepl. 12, 4058 Basel, Switzerland
In Basel's tallest habitable building, the HYPERION Hotel Basel is next to the Basel Messe trade fair center and just a short walk from the Old Town. It offers a sauna and a fitness center. Each of the 224 non-smoking guest rooms offers panoramic views of the city, free WiFi, air conditioning, refreshing bath products, a safe, hair dryer, and flat-screen TV with Sky channels.
PanAgora Pharma has a conference room block at the Hyperion Hotel Basel - just 1km from Roche Building 1. To book your room at the preferred room block rate, please use this link: CTIS Room Block at Hyperion Hotel Basel
***The Room Block closes on 13 May 2025, so we encourage all attendees staying in Basel to please make your reservation before then.
